000 01737 a2200469 4500
005 20250514050658.0
264 0 _c20030418
008 200304s 0 0 eng d
022 _a1046-6673
024 7 _a10.1097/01.asn.0000031804.77546.f5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTofovic, Stevan P
245 0 0 _a2-Hydroxyestradiol attenuates renal disease in chronic puromycin aminonucleoside nephropathy.
_h[electronic resource]
260 _bJournal of the American Society of Nephrology : JASN
_cNov 2002
300 _a2737-47 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aChronic Disease
650 0 4 _aCollagen Type IV
_xmetabolism
650 0 4 _aCytoprotection
650 0 4 _aEstradiol
_xanalogs & derivatives
650 0 4 _aGlomerular Filtration Rate
_xdrug effects
650 0 4 _aImmunohistochemistry
650 0 4 _aKidney Failure, Chronic
_xchemically induced
650 0 4 _aKidney Tubules
_xmetabolism
650 0 4 _aMale
650 0 4 _aProliferating Cell Nuclear Antigen
_xmetabolism
650 0 4 _aProteinuria
_xurine
650 0 4 _aPuromycin Aminonucleoside
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptors, Estrogen
_xmetabolism
650 0 4 _aReference Values
650 0 4 _aTransforming Growth Factor beta
_xmetabolism
700 1 _aDubey, Raghvendra
700 1 _aSalah, Eman M
700 1 _aJackson, Edwin K
773 0 _tJournal of the American Society of Nephrology : JASN
_gvol. 13
_gno. 11
_gp. 2737-47
856 4 0 _uhttps://doi.org/10.1097/01.asn.0000031804.77546.f5
_zAvailable from publisher's website
999 _c12205754
_d12205754